Sodium glucose cotransporter‐2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function-Reference-Cited by-同舟云学术

Sodium glucose cotransporter‐2 inhibitor was associated with an improvement in left ventricular systolic function in patients with type 2 diabetes mellitus with impaired left ventricular systolic function

Published:2020-07-06 Issue:5 Volume:7 Page:2784-2796
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Chan Yi‐Hsin¹²³,Hsu Tzyy‐Jer¹,Wang Chun‐Li¹²,Kao Yi‐Wei⁴,Huang Chien‐Ying¹,Chu Pao‐Hsien¹²

Affiliation:

1. The Cardiovascular Department Chang Gung Memorial Hospital, Linkou Taoyuan 33305 Taiwan

2. College of Medicine Chang Gung University Taoyuan 33302 Taiwan

3. Microscopy Core Laboratory Chang Gung Memorial Hospital, Linkou Taoyuan Taiwan

4. Graduate Institute of Business Administration, College of Management Fu Jen Catholic University Taipei Taiwan

Funder

Chang Gung Memorial Hospital

Ministry of Science and Technology

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12877

Reference27 articles.

1. Preventable Major Cardiovascular Events Associated With Uncontrolled Glucose, Blood Pressure, and Lipids and Active Smoking in Adults With Diabetes With and Without Cardiovascular Disease: A Contemporary Analysis

2. Diabetes and Cardiovascular Disease

3. Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences

4. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

5. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of SGLT-2 Inhibitors on Cardiac Function, Blood Glucose Levels, and Prognosis in Patients with Type 2 Diabetes Mellitus after Percutaneous Coronary Intervention: A Propensity Score Matching Study;The Heart Surgery Forum;2024-07-15

2. Dapagliflozin Effects on Cardiac Deformation in Heart Failure and Secondary Clinical Outcome;JACC: Cardiovascular Imaging;2024-07

3. Switch to gliflozins and biventricular function improvement in patients with chronic heart failure and diabetes mellitus;Clinical Physiology and Functional Imaging;2023-10-27

4. Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review;Cardiovascular Diabetology;2023-06-30

5. The impact of SGLT2 inhibition on imaging markers of cardiac function: A systematic review and meta-analysis;Pharmacological Research;2022-06